Literature DB >> 25179702

Association of small dense lowdensity lipoprotein cholesterol in type 2 diabetics with coronary artery disease.

Ya-Ching Huang, Pi-Yueh Chang, Jawl-Shan Hwang, Hsiao-Chen Ning1.   

Abstract

BACKGROUND: The risk of coronary artery disease (CAD) increases two- to fourfold in diabetes. Small dense low-density lipoprotein (sdLDL) particles have been linked to an increased risk for CAD. In this study, we sought to compare the sdLDL cholesterol (sdLDL-C) level between the healthy control group and diabetics with CAD in the Taiwanese population.
METHODS: Serum specimens were collected from healthy females and males of various age groups (n = 294), type 2 diabetics (DM) without complications (n = 113), and patients having DM with CAD (DM-CAD) (n = 46). The commercial kit was used for the measurement of sdLDL-C level, which employs a simpler method. After heparin-magnesium precipitation of lipoproteins with density <1.044 g/ml, sdLDL (density = 1.044-1.063 g/ml) remained in the supernatant and this sdLDL-C was measured using an automated chemistry analyzer.
RESULTS: The sdLDL-C level was significantly higher in males than in females (p < 0.001) and there was an age effect on sdLDL-C (p < 0.001). The DM-CAD group had significantly higher sdLDL-C levels than the healthy control group (p < 0.001), but there was no statistical difference in the LDL-C level between DM-CAD group and the healthy control group. In addition, only individuals having both high LDL-C and sdLDL-C levels had a higher risk for DM-CAD, compared to those with low LDL-C levels and low sdLDL-C levels [Odds Ratio (OR) 4.97; 95% Confidence Interval (CI) 1.96-12.57; p = 0.001].
CONCLUSIONS: Our data suggest that the sdLDL-C level together with the LDL-C level are better risk assessment markers for type 2 diabetics with CAD than the LDL-C level alone.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25179702     DOI: 10.4103/2319-4170.132883

Source DB:  PubMed          Journal:  Biomed J        ISSN: 2319-4170            Impact factor:   4.910


  7 in total

1.  Measured Versus Calculated Small Dense LDL-Cholesterol and Cardiometabolic Traits in a South African Population.

Authors:  M Masoud; A P Kengne; R T Erasmus; G M Hon; M Macharia; T E Matsha
Journal:  Indian J Clin Biochem       Date:  2018-03-22

2.  PCSK9 positively correlates with plasma sdLDL in community-dwelling population but not in diabetic participants after confounder adjustment.

Authors:  Yan Liu; Xiaona Wang; Jie Han; Lu Liu; Ying Jin; Liyuan Jin; Ping Ye
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

3.  Ezetimibe in Combination With Simvastatin Reduces Remnant Cholesterol Without Affecting Biliary Lipid Concentrations in Gallstone Patients.

Authors:  Osman Ahmed; Karin Littmann; Ulf Gustafsson; Camilla Pramfalk; Katariina Öörni; Lilian Larsson; Mirko E Minniti; Staffan Sahlin; German Camejo; Paolo Parini; Mats Eriksson
Journal:  J Am Heart Assoc       Date:  2018-12-18       Impact factor: 5.501

4.  Serum concentrations of small dense low-density lipoprotein cholesterol and lipoprotein(a) are related to coronary arteriostenosis in Takayasu arteritis.

Authors:  Si Chen; Haixia Luan; Jianxun He; Yan Wang; Shuang Liu; Yongzhe Li; Xiaoli Zeng; Hui Yuan
Journal:  J Clin Lab Anal       Date:  2021-10-28       Impact factor: 2.352

5.  Serum sdLDL-C and Cellular SREBP2-dependent Cholesterol Levels; is there a Challenge on Targeting PCSK9?

Authors:  Elham Soltanmohammadi; Sadegh Piran; Asghar Mohammadi; Bita Hosseni; Faezeh Naseri; Mohammad Shabani; Mohammad Najafi
Journal:  J Med Biochem       Date:  2016-11-02       Impact factor: 3.402

6.  The effect of atorvastatin treatment duration on oxidative stress markers and lipid profile in patients with coronary artery diseases: A case series study.

Authors:  Gholamreza Shahsavari; Amir Raoufi; Aram Toolabi; Nahid Hosseninejadmir; Hassan Ahmadvand; Mehdi Safariebrahimsarabie
Journal:  ARYA Atheroscler       Date:  2017-11

7.  Effect of a 90 g/day low-carbohydrate diet on glycaemic control, small, dense low-density lipoprotein and carotid intima-media thickness in type 2 diabetic patients: An 18-month randomised controlled trial.

Authors:  Chin-Ying Chen; Wei-Sheng Huang; Hui-Chuen Chen; Chin-Hao Chang; Long-Teng Lee; Heng-Shuen Chen; Yow-Der Kang; Wei-Chu Chie; Chyi-Feng Jan; Wei-Dean Wang; Jaw-Shiun Tsai
Journal:  PLoS One       Date:  2020-10-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.